title: Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI.
abstract: BACKGROUND
  Despite its frequency, the polycystic ovary syndrome (PCOS) is still a difficult diagnosis in endocrinology, gynecology, and reproductive medicine. The Rotterdam consensus conference proposed to include the ultrasonographic follicle count as a new diagnostic criterion. Unfortunately, its assessment does not offer sufficient reliability worldwide.
  
  
  OBJECTIVE
  To explore the possible roles of altered circulating androgens and anti-mullerian hormone among PCOS women regarding their body mass index and their outcomes after IVF.
  
  
  METHODS
  In this cross sectional study, 195 women with PCO were included, they were divided according to their body mass index (BMI <27 kg/m(2)) as obese PCOS (n=91) and overweight PCOS (BMI ≥27 kg/m(2)) (n=104). Serum levels of androgens (dehydroepiandrosterone sulfate [DHEAS], testosterone and androstenedione [A4]), and anti-mullerian hormone (AMH) were assessed and compared with the endocrine profile and cycles outcomes.
  
  
  RESULTS
  AMH, A4, FSH, and TSH concentrations were significantly higher in obese than in overweight women (p˂0.001). Contrary, LH: FSH ratio values, E2, PRL and DAHE-S levels were significantly lower in obese than in overweight women (p˂0.0001). Total oocyte retrieved, mature and fertilized oocyte were significantly higher in obese than in overweight women. Among pregnant obese PCOS women both AMH and A4 were significantly increased and DAHE-S was significantly decreased compared to pregnant overweight PCOS women.
  
  
  CONCLUSIONS
  Obese PCOS women have a higher chance of getting pregnant over those categorized as overweight PCOS. Also, androgens and AMH levels recommended to be considered in IVF attributes among obese and overweight PCOS women.
authors.affiliation: Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza, Egypt.
authors.forename: Menha
authors.initials: M
authors.lastname: Swellam
authors.affiliation: Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza, Egypt. ; Department of Biochemistry, El-Gouf University, Kingdom Saudi Arabia.
authors.forename: Abeer
authors.initials: A
authors.lastname: Khaial
authors.affiliation: Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza, Egypt.
authors.forename: Tamer
authors.initials: T
authors.lastname: Mosa
authors.affiliation: Department of Biochemistry, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza, Egypt. ; Department of Clinical Biochemistry, Faculty of Medicine, North Jeddah Branch, King Abdulaziz University, Kingdom Saudi Arabia.
authors.forename: Hatim
authors.initials: H
authors.lastname: El-Baz
authors.affiliation: Department of Obstetrics and Gynecology, Ain-Shams University, Cairo, Egypt.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Said
keywords: Androgen hormone; Androstenedione; Anti-mullerian hormone; Polycystic ovary syndrome